Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival

dc.contributor.author	Ergüven, M.
dc.contributor.author	Bilir, A.
dc.date.accessioned	2021-12-21T08:41:55Z
dc.date.available	2021-12-21T08:41:55Z
dc.date.issued	2012
dc.identifier.isbn	9789400742345; 9400742339; 9789400742338
dc.identifier.uri	https://doi.org/10.1007/978-94-007-4234-5_25
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1549
dc.description.abstract	Glioblastoma (GBM) is the most common and lethal brain tumor. Characterization of GBM with poor prognosis although new treatment modalities hasn't been changed up to date. New molecular targets in order to overcome resistance and recurrence are needed. Au
dc.language.iso	English
dc.publisher	Springer Netherlands
dc.title	Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival
dc.type	Book Chapter
dc.relation.journal	Midkine: From Embryogenesis to Pathogenesis and Therapy
dc.identifier.startpage	283
dc.identifier.endpage	303
dc.identifier.doi	10.1007/978-94-007-4234-5_25

Files in this item

Files	Size	Format	View
There are no files associated with this item.